Application no. and date | 14711899.6 (espacenet) (Federated) (European Patent Register), 20140305 | Patent/reg. no. and date | DK/EP 2970447, 20180516 | Publication date | 20160120 | Priority no. and date | US 201361792800 P, 20130315 | EP pub. no. and date |
EP 2970447 20160120 | Effective date | | Applicant/owner | Eli Lilly and Company, Lilly Corporate Center
Indianapolis, IN 46285, US | Applicant ref. no. | P81801678DK00E | Inventor | BEIDLER, Catherine Brautigam, c/o Eli Lilly and Company P. O. Box 6288
Indianapolis Indiana 46206-6288, US, KIKLY, Kristine Kay, c/o Eli Lilly and Company P. O. Box 6288
Indianapolis Indiana 46206-6288, US, STRIFLER, Beth Ann, c/o Eli Lilly and Company P. O. Box 6288
Indianapolis Indiana 46206-6288, US, WITCHER, Derrick Ryan, c/o Eli Lilly and Company P. O. Box 6288
Indianapolis Indiana 46206-6288, US, BOYLES, Jeffrey Streetman, c/o Eli Lilly and Company P. O. Box 6288
Indianapolis Indiana 46206-6288, US | Representative | Zacco Denmark A/S, Arne Jacobsens Allé 15, 2300 København S | Opponent | | IPC Class | C07K 16/18 (2006.01) , C07K 16/24 (2006.01) | Title | PAN-ELR+ CXC KEMOKIN-ANTISTOFFER | Int. application no. | US2014020605 | Int. publication no. | WO2014149733 | Related patent (certificate) | | Status | DK/EP patent | Pædiatrisk forlængelse | - | Udløbsdato for pædiatrisk forlængelse | - |
|